Bio-Techne
TECH
#2472
Rank
HK$58.09 B
Marketcap
HK$371.08
Share price
1.43%
Change (1 day)
1.74%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2026 (TTM): HK$5.54

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is HK$5.56. In 2025 the company made an earnings per share (EPS) of HK$4.07 a decrease over its 2024 EPS that were of HK$7.83.

EPS history for Bio-Techne from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$5.5435.91%
2025HK$4.07-48%
2024HK$7.83-29.58%
2023HK$11.12-14.97%
2022HK$13.0824.16%
2021HK$10.5417.98%
2020HK$8.93-10.94%
2019HK$10.03101.57%
2018HK$4.97-16.99%
2017HK$5.9945.02%
2016HK$4.13-20.97%
2015HK$5.23-14.97%
2014HK$6.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
HK$142.73 2,466.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
HK$42.77 669.01%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$64.16 1,053.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
HK$40.66 630.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
HK$16.14 190.15%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-HK$1.65-129.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
HK$47.86 760.56%๐Ÿ‡บ๐Ÿ‡ธ USA